BEAM THERAPEUTICS INC.: PLANS TO ENGAGE FDA ON POTENTIAL PATH TO APPROVAL; ENROLLMENT IN 60 MG DOSE COHORT UNDERWAY

Reuters · 3d ago

Please log in to view news